← FDA Drug Approvals (Drugs@FDA)

STAVUDINE; LAMIVUDINE; EFAVIRENZ

NDA · New Drug Application · Sponsor: STRIDES ACROLAB · Approved 2007-06-01

Drug application

FDA Application #

NDA022097

Application type

New Drug Application

Brand name

STAVUDINE; LAMIVUDINE; EFAVIRENZ

Generic name

Stavudine

Active ingredients

STAVUDINE; LAMIVUDINE; EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

STRIDES ACROLAB

First approval

2007-06-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown